DRP1 Inhibitor DRP1i2 Protects Hearts from Doxorubicin-Induced Damage
Doxorubicin has helped transform the treatment of many cancers, but the drug carries a dangerous biological trade-off: it can damage ...
Doxorubicin has helped transform the treatment of many cancers, but the drug carries a dangerous biological trade-off: it can damage ...
In an unprecedented study published by researchers at the forefront of pharmacology and toxicology, the mechanism of cisplatin-induced toxicity in ...
In a groundbreaking advance poised to shift the paradigm of cancer therapy management, researchers have unveiled compelling evidence that empagliflozin, ...
Cancer diagnosis presents one of the most daunting challenges in modern medicine. Yet for countless patients, the struggle does not ...
In a compelling new study emerging from Turkey, researchers have illuminated the often-overlooked interplay between cognitive dysfunction and depression among ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine